Tachibana Takayoshi, Nakayama Naoki, Matsumura Ayako, Nakajima Yuki, Takahashi Hiroyuki, Miyazaki Takuya, Nakajima Hideaki
Department of Hematology and Clinical Immunology, Yokohama City University Hospital, Japan.
Department of Hematology, Kanagawa Cancer Center, Japan.
Intern Med. 2017 Sep 15;56(18):2487-2492. doi: 10.2169/internalmedicine.8629-16. Epub 2017 Aug 21.
A 65-year-old man was diagnosed with polycythemia vera (PV) and treated with hydroxyurea. Three years later, he was admitted to our institution for severe hypoxia. Right heart catheterization revealed that the patient had pulmonary hypertension (PH). In addition, radiographic findings and resistance to pulmonary vasodilators led to the diagnosis of PH associated with pulmonary veno-occlusive disease. The administration of ruxolitinib improved his hematopoiesis and respiratory failure. While the disease is relatively common in Europe and the United States, limited data exist regarding myeloproliferative neoplasm complicated with PH in Japan. PH should be considered a potential complication and screened during the clinical care of patients with myeloproliferative neoplasms.
一名65岁男性被诊断为真性红细胞增多症(PV)并接受羟基脲治疗。三年后,他因严重缺氧入住我院。右心导管检查显示该患者患有肺动脉高压(PH)。此外,影像学检查结果及对肺血管扩张剂的耐药性导致诊断为与肺静脉闭塞性疾病相关的PH。芦可替尼的使用改善了他的造血功能和呼吸衰竭。虽然该疾病在欧洲和美国相对常见,但关于日本骨髓增殖性肿瘤合并PH的数据有限。在骨髓增殖性肿瘤患者的临床护理中,应将PH视为一种潜在并发症并进行筛查。